Emerging Signaling Pathways in Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1664-5553|1|2|83-93

ISSN： 2235-1795

Source： Liver Cancer, Vol.1, Iss.2, 2012-09, pp. : 83-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Strategies for the Management of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 32, Iss. 6, 2014-10 ,pp. : 655-657

Karger

Access to resources Recommend Favorite

TGF-β Signaling in Onset and Progression of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 30, Iss. 5, 2012-10 ,pp. : 514-523

Karger

Access to resources Recommend Favorite

Signaling Pathway and Molecular-Targeted Therapy for Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 29, Iss. 3, 2011-08 ,pp. : 289-302

Karger

Access to resources Recommend Favorite

Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma

By Miyoshi Hideyuki   Fujie Hajime   Moriya Kyoji   Shintani Yoshizumi   Tsutsumi Takeya   Makuuchi Masatoshi   Kimura Satoshi   Koike Kazuhiko  

Journal of Gastroenterology, Vol. 39, Iss. 6, 2004-06 ,pp. : 563-569

Springer Publishing Company

Access to resources Recommend Favorite

Suppressor of cytokine signaling 1, a newly proposed tumor suppressor gene associated with hepatocellular carcinoma

By Ohkawa Kazuyoshi  

Journal of Gastroenterology, Vol. 39, Iss. 6, 2004-06 ,pp. : 598-600

Springer Publishing Company

Access to resources Recommend Favorite